Pulse isn't just a feature; it's a strategic move. By proactively delivering personalized updates from chats and connected apps, OpenAI is building a deep user knowledge graph. This transforms ChatGPT from a reactive tool into a proactive assistant, laying the groundwork for autonomous agents and targeted ads.

AI serves as a powerful health advocate by holistically analyzing disparate data like blood work and symptoms. It provides insights and urgency that a specialist-driven system can miss, empowering patients in complex, under-researched areas to seek life-saving care.

An effective AI strategy in healthcare is not limited to consumer-facing assistants. A critical focus is building tools to augment the clinicians themselves. An AI 'assistant' for doctors to surface information and guide decisions scales expertise and improves care quality from the inside out.

The value of a personal AI coach isn't just tracking workouts, but aggregating and interpreting disparate data types—from medical imaging and lab results to wearable data and nutrition plans—that human experts often struggle to connect.

Moving beyond simple commands (prompt engineering) to designing the full instructional input is crucial. This "context engineering" combines system prompts, user history (memory), and external data (RAG) to create deeply personalized and stateful AI experiences.

Instead of replacing experts, AI can reformat their advice. It can take a doctor's diagnosis and transform it into a digestible, day-by-day plan tailored to a user's specific goals and timeline, making complex medical guidance easier to follow.

To get higher-quality input from busy medical experts, use specialized AI tools like Consensus.app to review scientific literature first. Then, present your tentative conclusions to the professional, demonstrating you've done the preliminary work, which encourages a more thoughtful and detailed response.

The future of biotech moves beyond single drugs. It lies in integrated systems where the 'platform is the product.' This model combines diagnostics, AI, and manufacturing to deliver personalized therapies like cancer vaccines. It breaks the traditional drug development paradigm by creating a generative, pan-indication capability rather than a single molecule.

A major frustration in genetics is finding 'variants of unknown significance' (VUS)—genetic anomalies with no known effect. AI models promise to simulate the impact of these unique variants on cellular function, moving medicine from reactive diagnostics to truly personalized, predictive health.